Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Is the superparamagnetic iron oxide nanoparticle a suitable carrier for the anticancer drug lenalidomide? A quantum chemical approach

Year: 1400
COI: JR_ICR-5-2_010
Language: EnglishView: 72
This Paper With 6 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 6 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Monir Teymoori - Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran
Ali Morsali - Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran
Mohammad Bozorgmehr - Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran
S. Ali Beyramabadi - Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran

Abstract:

The use of superparamagnetic iron oxide nanoparticles (SION) in targeted drug delivery has become widespread because they can be directed at cancerous tissue by applying an external magnetic field. In this work, we used quantum chemical calculations to investigate whether SIONs are suitable for the anticancer drug lenalidomide (LLM). For this purpose, using a suitable model for SION in aqueous solution, seven possible configurations of drug-carrier interaction were considered (SION/LLM۱-۷). The binding energies of optimized configurations were evaluated at M۰۶-۲X/۶-۳۱G(d,p). The most stable configurations (SION/LLM۶ and SION/LLM۷) occur when the drug is parallel to the nanoparticle ring. In these cases, the most and strongest hydrogen bonds are obtained. Large negative values of binding and solvation energies indicate high drug loading and acceptable solubility. Due to the essential role of hydrogen bonds in this drug delivery system, these bonds were studied in detail by quantum theory of atoms in molecules (QTAIM).

Keywords:

superparamagnetic iron oxide nanoparticles , Lenalidomide , DFT , AIM analysis , Drug Delivery

Paper COI Code

This Paper COI Code is JR_ICR-5-2_010. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1365175/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Teymoori, Monir and Morsali, Ali and Bozorgmehr, Mohammad and Beyramabadi, S. Ali,1400,Is the superparamagnetic iron oxide nanoparticle a suitable carrier for the anticancer drug lenalidomide? A quantum chemical approach,https://civilica.com/doc/1365175

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: Azad University
Paper count: 10,491
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support